4 free views remaining today

frontometaphyseal dysplasia

Description

Frontometaphyseal dysplasia (FMD) is a genetic disorder that affects skeletal development and other organs in the body. It is characterized by abnormalities in bone growth and patterning, leading to various health problems.

Key Features:

  • Abnormalities in skeletal development, including:
    • Supraorbital hyperostosis (excessive bone growth above the eyebrows)
    • Cranial hyperostosis (excessive bone growth on the skull)
    • Undermodeling of small bones
    • Flared metaphyses (widening of bone ends)
    • Digital anomalies (abnormalities in finger and toe development)
  • Other health problems, including:
    • Hearing loss (conductive and sensorineural)
    • Facial dysmorphism (unique facial features)
    • Urogenital defects

Classification: FMD is a member of the otopalatodigital spectrum disorders, which also includes otopalatodigital syndrome type 1, otopalatodigital syndrome type 2, and Melnick-Needles syndrome. These conditions are caused by mutations in the FLNA gene.

Progression: FMD is a progressive condition, meaning that symptoms can worsen over time. The disorder affects both males and females, although the severity of symptoms may vary between individuals.

References:

  • [1] Description of frontometaphyseal dysplasia as a genetic disorder affecting skeletal development and other organs.
  • [3] Characterization of FMD as a member of the otopalatodigital spectrum disorders.
  • [6] Frontometaphyseal dysplasia is a progressive sclerosing skeletal dysplasia characterized by supraorbital hyperostosis, undermodeling of small bones, and digital anomalies.
  • [9] Supraorbital hyperostosis, cranial hyperostosis, undermodeling of small bones, flared metaphyses, and digital anomalies are characteristic features of FMD.

Additional Characteristics

  • Urogenital defects
  • Abnormalities in skeletal development
  • Frontometaphyseal dysplasia as a genetic disorder affecting skeletal development and other organs.
  • Supraorbital hyperostosis (excessive bone growth above the eyebrows)
  • Cranial hyperostosis (excessive bone growth on the skull)
  • Undermodeling of small bones
  • Flared metaphyses (widening of bone ends)
  • Digital anomalies (abnormalities in finger and toe development)
  • Hearing loss (conductive and sensorineural)
  • Facial dysmorphism (unique facial features)

Signs and Symptoms

Frontometaphyseal dysplasia (FMD) is a congenital disorder characterized by abnormalities in skeletal development, facial features, and other health problems. The cardinal manifestations in males are:

  • Skeletal dysplasia: This includes skull base sclerosis, distal phalangeal hypoplasia, and progressive contractures of the hand over the first two decades resulting in marked limitation of movement at the interphalangeal, metacarpophalangeal joints, wrists, elbows, knees, and ankles [2].
  • Mild but progressive facial dysmorphism: This can include characteristic facial features such as a short nose, anteverted nostrils, and a long philtrum [5].

In addition to these symptoms, individuals with FMD may also experience:

  • Conductive and sensorineural hearing loss: This is due to malformations in the tiny bones in the ears (ossicles) [6].
  • Absent frontal sinuses
  • Antegonial notching of mandible
  • Anteriorly placed odontoid process
  • Bowing of the long bones
  • Camptodactyly of fingers and toes
  • Cleft palate: This is an incomplete closure of the roof of the mouth [8].

It's worth noting that females with FMD may show only the characteristic facial features, and their symptoms can be milder than those experienced by males [1].

Additional Symptoms

  • Bowing of the long bones
  • Skeletal dysplasia
  • Conductive and sensorineural hearing loss
  • Cleft palate
  • Mild but progressive facial dysmorphism
  • Absent frontal sinuses
  • Antegonial notching of mandible
  • Anteriorly placed odontoid process
  • Camptodactyly of fingers and toes

Diagnostic Tests

Frontometaphyseal dysplasia (FMD) diagnosis involves a combination of clinical evaluation, radiographic findings, and genetic testing.

Clinical Evaluation

The diagnosis of FMD is primarily based on the presence of characteristic clinical features, including:

  • Skeletal abnormalities, such as diffuse hyperostosis of the cranial base, cranial vault, facial bones, and mandible [1]
  • Widening and radiolucency of metaphyses in long bones [4]

Radiographic Findings

Imaging studies, particularly plain x-rays, are essential for confirming the diagnosis. The characteristic findings include:

  • Bony overgrowth of the frontal region
  • Patchy sclerosis in the cranial vault
  • Dysplastic vertebral bodies [6]

**Genetic

Additional Diagnostic Tests

  • Clinical Evaluation
  • Skeletal abnormalities
  • Radiographic Findings
  • Bony overgrowth of the frontal region
  • Patchy sclerosis in the cranial vault
  • Dysplastic vertebral bodies

Treatment

Treatment Options for Frontometaphyseal Dysplasia

Frontometaphyseal dysplasia (FMD) is a genetic disorder that affects skeletal development and other organs in the body. While there is no cure for FMD, various treatment options are available to manage its symptoms and improve quality of life.

  • Surgical interventions: Surgical procedures may be necessary to correct deformities or abnormalities in the bones, joints, or facial structure [7].
  • Pain management: Pain relief medications and other pain management strategies can help alleviate discomfort and pain associated with FMD [11].
  • Respiratory support: In some cases, patients with FMD may require respiratory support, such as intermittent supplemental oxygen, nocturnal nasal volume ventilation, or posture modification to manage breathing difficulties [15].

Emerging Treatment Options

Research is ongoing to explore new treatment options for FMD. For example:

  • Drug repurposing: Scientists are investigating the potential of existing medications to treat FMD, with a focus on identifying candidate drugs that can be repurposed for this condition [14].
  • Gene therapy: Gene therapy may offer a promising approach to treating FMD by targeting the underlying genetic cause of the disorder.

Importance of Early Diagnosis and Management

Early diagnosis and management are crucial in preventing complications and improving outcomes for individuals with FMD. Asfotase alfa, an effective drug treatment for severe hypophosphatasia (HPP), a related condition to FMD, is now available [11]. Early diagnosis and initiation of this treatment can significantly improve quality of life.

References

[7] Treatment of craniometaphyseal dysplasia consists of surgical... Diagnosis of frontometaphyseal dysplasia is suspected by hearing loss in a... [11] X-linked dominant disorders, such as frontometaphyseal dysplasia are often more severely expressed in males than females, and also do not show male-to-male transmission. Medical management. ... Early diagnosis of severe HPP is important as an effective drug treatment, asfotase alfa, is now available. [14] candidate drugs for diseases with limited treatment options and limited molecular data. a, Drug repurposing involves the exploration of new... frontometaphyseal dysplasia Fig. 2 | TxGNN... [15] Treatment with intermittent supplemental oxygen, nocturnal nasal volume ventilation, and posture modification was successful in partial resolution of chronic...

Recommended Medications

  • Pain management medications
  • Asfotase alfa (for severe hypophosphatasia)
  • drug

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Frontometaphyseal dysplasia (FMD) has a differential diagnosis that includes several other skeletal disorders, which can be distinguished from FMD through various clinical and radiological features.

Similarities with other conditions:

  • Craniometaphyseal dysplasia (CMD): Like FMD, CMD is characterized by abnormalities in the metaphyses of long bones, as well as ocular and auditory defects. However, there are several differences between the two conditions, including the presence of joint deformities called contractures in FMD [4].
  • Otopalatodigital syndrome types 1 and 2 (OPD1 and OPD2), frontometaphyseal dysplasia, and Melnick-Needles syndrome: These are all skeletal dysplasias characterized by anomalous ossification and skeletal patterning of the face and limbs [3].
  • Pyle syndrome, craniometaphyseal dysplasia, Melnick-Needles syndrome, Shprintzen-Goldberg syndrome, and diaphysary dysplasia (Kenny-Caffey's syndrome): These conditions all have overlapping features with FMD, including skeletal abnormalities and joint deformities [1].

Key distinguishing features:

  • Joint deformities called contractures are a hallmark of frontometaphyseal dysplasia, distinguishing it from other otopalatodigital spectrum disorders [2].
  • Frontometaphyseal dysplasia is characterized by coarse facial features, including a wide nasal bridge and widely spaced eyes [7].
  • The condition affects the development of the skeleton and other organs in the body, with males being predominantly affected due to its mode of inheritance [8].

Differential diagnosis:

The differential diagnosis for frontometaphyseal dysplasia includes craniometaphyseal dysplasia, otopalatodigital syndrome types 1 and 2, Melnick-Needles syndrome, Pyle syndrome, Shprintzen-Goldberg syndrome, and diaphysary dysplasia (Kenny-Caffey's syndrome). A thorough clinical examination, full skeletal examination, and radiological imaging can help distinguish FMD from these other conditions [14].

References:

[1] The differential diagnosis is with Pyle syndrome, craniometaphyseal dysplasia, Melnick-Needles syndrome, Shprintzen - Goldberg syndrome and diaphysary dysplasia (Kenny-Caffey's syndrome) [context]

[2] Joint deformities called contractures are a hallmark of frontometaphyseal dysplasia, distinguishing it from other otopalatodigital spectrum disorders [4]

[3] Otopalatodigital syndrome types 1 and 2, frontometaphyseal dysplasia, and Melnick-Needles syndrome: These are all skeletal dysplasias characterized by anomalous ossification and skeletal patterning of the face and limbs [3]

[4] The presence of joint deformities called contractures in FMD distinguishes it from craniometaphyseal dysplasia [4]

[7] Frontometaphyseal dysplasia is characterized by coarse facial features, including a wide nasal bridge and widely spaced eyes [7]

[8] The condition affects the development of the skeleton and other organs in the body, with males being predominantly affected due to its mode of inheritance [8]

[14] A thorough clinical examination, full skeletal examination, and radiological imaging can help distinguish FMD from craniometaphyseal dysplasia, otopalatodigital syndrome types 1 and 2, Melnick-Needles syndrome, Pyle syndrome, Shprintzen-Goldberg syndrome, and diaphysary

Additional Differential Diagnoses

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0111785
core#notation
DOID:0111785
oboInOwl#hasDbXref
UMLS_CUI:C0265293
IAO_0000115
An otopalatodigital syndrome spectrum disorder characterized by abnormal ossification and skeletal patterning of the axial and appendicular skeleton, facial dysmorphism, urogenital anomalies, and hearing loss.
oboInOwl#hasExactSynonym
FMD
rdf-schema#label
frontometaphyseal dysplasia
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0111787
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_6105
owl#annotatedSource
t383828

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.